FIELD: medicine.
SUBSTANCE: access to the salivary gland is obtained by one of the standard skin incisions in prootic area, based on tumour location. The affected part is seected and excised within healthy tissues. In this case, after removal of the affected part of the salivary gland, salivary gland slices visible in the surgical wound are infiltrated with type A botulinum toxin solution, 1-2 units in each slice. Soft tissue is sutured, and sutures are imposed on the skin, an aseptic bandage is applied.
EFFECT: reduced time of treatment and rehabilitation by accelerating the regeneration of the post-operative wound, prevention of salivation in early postoperative period and salivary fistula formation in late postoperative period.
4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ELIMINATING DEFORMATION OF THE PAROTIDEOMASSETERIC REGION WITH A VASCULARISED FLAP OF SUPERFICIAL TEMPORAL FASCIA AFTER PAROTIDECTOMY | 2022 |
|
RU2783454C1 |
METHOD FOR ELIMINATING DEFECT AND DEFORMATION OF THE PAROTIDEOMASSETERIC REGION WITH A SUPERFICIAL MUSCULO-APONEUROTIC SYSTEM (SMAS) | 2022 |
|
RU2783455C1 |
METHOD OF SURGICAL ACCESS WHEN PERFORMING OPERATIONS TO REMOVE BENIGN TUMORS OF THE PAROTID SALIVARY GLAND | 2022 |
|
RU2795538C1 |
METHOD FOR REMOVAL OF PLEOMORPHIC ADENOMA OF PAROTID SALIVARY GLAND | 2023 |
|
RU2820089C1 |
METHOD OF REMOVING TUMORS OF CRANIOVERTEBRAL LOCALISATION | 2015 |
|
RU2599688C1 |
METHOD OF SURGICAL ACCESS IN CASE OF CERVICAL LYMPH NODE DISSECTION | 2014 |
|
RU2570166C2 |
METHOD FOR REMOVAL OF NEOPLASM OF DEEP LOBE OF PAROTID SALIVARY GLAND | 2023 |
|
RU2824832C1 |
METHOD FOR TREATMENT OF BENIGN TUMOR OF PAROTID SALIVARY GLANDS | 0 |
|
SU1806609A1 |
METHOD FOR SURGICAL TREATMENT OF SALIVARY GLAND TUMORS | 1994 |
|
RU2077277C1 |
METHOD FOR SURGICAL RECONSTRUCTION OF POSTOPERATIVE DEFECT OF PAROTID-MASTICATORY REGION IN TREATING NEW GROWTHS OF PAROTID SALIVARY GLAND | 2023 |
|
RU2822702C1 |
Authors
Dates
2017-05-02—Published
2016-06-06—Filed